Semaglutide
Long-acting GLP-1 analogue, studied in metabolic and appetite signaling models.
Out of stock
Get notified when Semaglutide (10 mg) is back in stock.
Research Overview
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist structurally derived from native GLP-1. Modifications to the peptide backbone extend its half-life, allowing once-weekly dosing in clinical settings. It has become one of the most studied incretin mimetics in metabolic and appetite-regulation research.
Areas of Interest
Laboratory studies of Semaglutide have investigated a variety of promising areas:
- •GLP-1 receptor pharmacology — studied as a reference long-acting GLP-1 agonist with high receptor affinity and resistance to DPP-4 degradation.
- •Appetite & satiety signalling — investigated in research models of central appetite regulation and hypothalamic satiety pathways.
- •Glycaemic control & insulin secretion — explored in models of glucose-stimulated insulin secretion and glycaemic regulation.
- •Body-weight & energy-balance research — examined in preclinical obesity models for effects on energy-balance regulation and weight-loss endpoints.
- •Cardiovascular & metabolic endpoints — studied in research models of cardiovascular and metabolic risk for effects on lipid profiles and vascular function.
As a research-grade reference material, our Semaglutide is supplied as a lyophilized powder with a purity of ≥99.2% as verified by HPLC and mass spectrometry. Each batch is accompanied by a Certificate of Analysis documenting sequence integrity, molecular weight confirmation, and chromatographic purity.
Technical Specifications
- Lyophilized
- Reconstitute with BAC water
- Store −20 °C
Certificate of Analysis
No reviews yet. Be the first to review this product.
Growth hormone releasing peptide (GHRP) analogue investigated in metabolic and recovery research.
Mitochondrial-derived peptide studied in metabolic regulation and exercise-mimetic research.
Triple agonist (GLP-1 / GIP / GCG) under investigation in metabolic research.
GHRH analogue studied for visceral adipose tissue research models.
Sold for in vitro laboratory and research purposes. Not a drug, food, cosmetic, dietary supplement, or medical device. Not for human or animal consumption.